Skip to Content

Vectura Group PLC

Rating as of

Company Profile

Business Description

Vectura Group PLC is engaged in inhaled product formulation, device design and development business offering an integrated inhaled drug delivery platform. The company has developed inhalation products to help patients suffering from airways diseases. It has approx ten key inhaled and eleven non-inhaled products marketed by partners with global royalty streams, and a diverse partnered portfolio of drugs in clinical development. The company's partners include Hikma, Novartis, Sandoz, Mundipharma, Kyorin, Baxter, GSK, UCB, Bayer, Chiesi, Almirall, Dynavax and Tianjin KingYork. The company operates in the United Kingdom, Japan, Switzerland, the United States of America, and Rest of the world with maximum revenue from the United Kingdom.

One Prospect West
Chippenham, Wiltshire, SN14 6FH, United Kingdom
T +44 1249667700
Sector Healthcare
Industry Drug Manufacturers - General
Most Recent Earnings
Fiscal Year End Dec 31, 2020
Stock Type
Employees 427